User:Trevor J. Petcher

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m
Line 1: Line 1:
-
Short summary of my background, skills, and milestones to be added later, as will a CV, and a PDF version of my talk in Erice, 30th May, 2008.
+
CV and a PDF version of my talk in Erice, 30th May, 2008 to be added later.
 +
Birthdate 1943, now retired after 37 years in the pharmaceutical industry (one company). British nationality, resident in Switzerland.
 +
 
 +
Languages English, German, Swiss German, passable French, smatterings of Italian, Spanish, and Portugese.
 +
 
 +
B.Sc. (Chemistry) 1964, PhD. (Chemical Crystallography) 1967, both University of Sheffield, England.
 +
 
 +
Small-molecule crystallographer 1967-1979 (1967-71 postdoc with Peter J. Pauling, UCL London, 1971-79 industrial small molecule crystallographer Sandoz Pharma AG, Basel),
 +
Molecular pharmacologist 1979-81,
 +
Middle management 1979-1992,
 +
Senior management 1992-2008,
 +
Drug designer,
 +
Molecular Modeller (especially small cyclic peptides),
 +
Promotor of productive dialogue between medicinal chemists and pharmacologists, molecular biologists, and structural biologists, 1979-2008,
 +
Head of a small group of medicinal chemists 1985-1989,
 +
Requested to initiate medicinal chemistry on peptidomimetics, especially of somatostatin 1989-1992,
 +
Certified "Chief Designer and Devil's Advocate" by the heads of my old department upon leaving in 1992,
 +
Staff Head Preclinical Research, Sandoz Pharma Basel 1992-1996,
 +
Head of Planning & Operations, Novartis Research Therapeutic Area Arthritis & Bone Metabolism (ABM) 1996-2008 (department twice re-organised to "Bone Metabolism & Gastrointestinal Diseases" (BMG) and finally to "Musculoskeletal Diseases" (MSD) in that period).
 +
 
 +
Broad experience in CNS (neuroleptics), Cardiovascular (beta blockers), Pain (major and minor analgesics), Endocrinology (inhibition of the secretion of pituitary hormones), Bone Metabolism, Gastroenterology (5-HT3,4), Immunology & Transplantation (especially cyclosporins), Arthritis (rheumatoid- and osteo-), and finally Muscle Disorders.
 +
 
 +
Co-inventer of octreotide (SMS 201-995, Sandostatin),
 +
Inventor of the class of octahydrobenzo[g]quinolines as replacement for ergot alkaloids and ergolines, co-inventor of quinagolide (SDZ 205-502, Norprolac)
 +
 
 +
Awards:
 +
Sandoz Golden Triangle for Entrepreneurship 1996 (with Wilfried Bauer, Peter Marbach) for Sandostatin.
 +
ACS Heroes of Chemistry 2000 (with Wilfied Bauer) for invention and development of Sandostatin.

Revision as of 08:12, 3 June 2008

CV and a PDF version of my talk in Erice, 30th May, 2008 to be added later. Birthdate 1943, now retired after 37 years in the pharmaceutical industry (one company). British nationality, resident in Switzerland.

Languages English, German, Swiss German, passable French, smatterings of Italian, Spanish, and Portugese.

B.Sc. (Chemistry) 1964, PhD. (Chemical Crystallography) 1967, both University of Sheffield, England.

Small-molecule crystallographer 1967-1979 (1967-71 postdoc with Peter J. Pauling, UCL London, 1971-79 industrial small molecule crystallographer Sandoz Pharma AG, Basel), Molecular pharmacologist 1979-81, Middle management 1979-1992, Senior management 1992-2008, Drug designer, Molecular Modeller (especially small cyclic peptides), Promotor of productive dialogue between medicinal chemists and pharmacologists, molecular biologists, and structural biologists, 1979-2008, Head of a small group of medicinal chemists 1985-1989, Requested to initiate medicinal chemistry on peptidomimetics, especially of somatostatin 1989-1992, Certified "Chief Designer and Devil's Advocate" by the heads of my old department upon leaving in 1992, Staff Head Preclinical Research, Sandoz Pharma Basel 1992-1996, Head of Planning & Operations, Novartis Research Therapeutic Area Arthritis & Bone Metabolism (ABM) 1996-2008 (department twice re-organised to "Bone Metabolism & Gastrointestinal Diseases" (BMG) and finally to "Musculoskeletal Diseases" (MSD) in that period).

Broad experience in CNS (neuroleptics), Cardiovascular (beta blockers), Pain (major and minor analgesics), Endocrinology (inhibition of the secretion of pituitary hormones), Bone Metabolism, Gastroenterology (5-HT3,4), Immunology & Transplantation (especially cyclosporins), Arthritis (rheumatoid- and osteo-), and finally Muscle Disorders.

Co-inventer of octreotide (SMS 201-995, Sandostatin), Inventor of the class of octahydrobenzo[g]quinolines as replacement for ergot alkaloids and ergolines, co-inventor of quinagolide (SDZ 205-502, Norprolac)

Awards: Sandoz Golden Triangle for Entrepreneurship 1996 (with Wilfried Bauer, Peter Marbach) for Sandostatin. ACS Heroes of Chemistry 2000 (with Wilfied Bauer) for invention and development of Sandostatin.

Proteopedia Page Contributors and Editors (what is this?)

Trevor J. Petcher, Eran Hodis

Retrieved from "http://52.214.119.220/wiki/index.php/User:Trevor_J._Petcher"
Personal tools